Mikio Sugimoto

Targeting Glucose Metabolism in Bladder Cancer: Therapeutic Implications of 2-Deoxy-D-glucose

Bladder cancer is characterized by metabolic reprogramming, and enhanced glycolysis contributes to tumor progression and therapeutic resistance. Because the anticancer activity of 2-deoxy-D-glucose (2-DG) has been reported in several malignancies, this study evaluated the antipro...